Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy

Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy

Abstract The prevalence of cardiomyopathy is higher in diabetic patients than those without diabetes. Diabetic cardiomyopathy (DCM) is defined as a clinical condition of abnormal myocardial structure and performance in diabetic patients without other cardiac risk factors, such as coronary artery dis...

Full description

Bibliographic Details
Main Authors: Lin Wang, Yin Cai, Liguo Jian, Chi Wai Cheung, Liangqing Zhang, Zhengyuan Xia
Format: Article
Language:English
Published: BMC 2021-01-01
Series:Cardiovascular Diabetology
Subjects:
Diabetic cardiomyopathy
PPARα modulator
Metformin
Glucagon-like peptide 1-receptor agonists
Sodium–glucose co-transporter type 2 inhibitors
Online Access:https://doi.org/10.1186/s12933-020-01188-0

Internet

https://doi.org/10.1186/s12933-020-01188-0

Similar Items